drugset / Trial / NCT04537299

COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes

NCT04537299

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test whether Fisetin, a senolytic drug, can assist in preventing an increase in the disease's progression and alleviate complications of coronavirus due to an excessive inflammatory reaction.

Timeline

Start
2022-04-29
Primary completion
2024-08-31
Completion
2024-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fisetin Small molecule 20 mg/kg Oral

Indications